[Invitation] EClinCloud Invites You to the September 2 Salon on Drug Clinical Trial Development Experience and Skills

Source: EClinCloud. Author: EClinCloud.
Salon on Drug Clinical Trial Development Experience and Skills

As China's biopharmaceutical sector accelerates into a new phase centered on innovative R&D, the number of drugs advancing from the laboratory to the clinic is surging. Unlike generic drug development, which follows an established path, clinical trials for innovative drugs involve far more exploration without a clear precedent. Accordingly, improving the skills of biopharmaceutical clinical trial practitioners is essential to addressing one of the key bottlenecks in accelerating the market entry of innovative drugs.
On September 2, 2022, the Salon on Drug Clinical Trial Development Experience and Skills will be held in Chengdu. Dr. Qin Long, CEO of EClinCloud, will join industry experts to discuss the many challenges facing clinical trials for innovative drugs across areas including trial design, biostatistical analysis, and clinical trial big data, aiming to present attendees with a complete picture of clinical trial experience and help practitioners enhance their skills.
(Attendance for this salon is limited to 80 participants)
Hosts:
Chengdu Tianhe Traditional Chinese and Western Medicine Technology Incubation Co., Ltd.
Sichuan Provincial Science and Technology Resource Sharing Service Platform for Pharmaceutical R&D Technological Innovation
Co-Host:
Chengdu Hi-Tech Investment Biomedical Park Management Co., Ltd.
Supporting Organizations:
Chengdu Fanweixi Pharmaceutical Technology Co., Ltd.
Chengdu Xingpulai Data Analysis Co., Ltd.
Chengdu Yaoyouzhijia Pharmaceutical Technology Co., Ltd.
Chengdu Saimeisi Medical Technology Co., Ltd.
Chengdu Qisheng Heyan Pharmaceutical Technology Co., Ltd.
Chongqing Yaoda Big Data Co., Ltd.
Boji Medical Technology Co., Ltd.
Jiangsu Lihua Biotechnology Co., Ltd.
Inner Mongolia Jingdong Pharmaceutical Co., Ltd.
Ya'an Xunkang Pharmaceutical Co., Ltd.
EClinCloud (Shenzhen) Technology Co., Ltd.
Yaorongquan, Xiangrong (Shanghai) Biotechnology Co., Ltd.
Guest Speakers

Jiang Xuehua
President, Sichuan Pharmaceutical Association
Former Professor and Doctoral Advisor, West China School of Pharmacy, Sichuan University
Former Chair, Department of Clinical Pharmacy and Pharmacy Administration, and Former Director, Clinical Pharmacy Research Center, West China School of Pharmacy, Sichuan University
Presentation Topic: "Bioequivalence Evaluation of Endogenous Drugs"

Liang Maozhi
Researcher, Department of Clinical Research Management
Vice Chair, Clinical Trial Ethics Committee, West China Hospital
Vice Chair, Biomedical Ethics Committee, West China Hospital
Presentation Topic: "Discussion on Selected Issues in Designing Clinical Trial Development Pathways for Innovative Drugs"

Qin Long
CEO, EClinCloud (Shenzhen) Technology Co., Ltd.
With over 16 years of experience in technology applications for the clinical research industry, he is a pioneer in promoting and implementing technical solutions such as eCOA, EDC, CTMS, and Argus in China's clinical trial research field.
Presentation Topic: "Scale and Rating Management in Clinical Research"

Zhu Yanfei
General Manager, Boyi Fund
Presentation Topic: "Biopharmaceutical Investment Opportunities and Responses in the New Environment"

Li Xiaopeng
General Manager, Chengdu Xingpulai Data Analysis Co., Ltd.
Presentation Topic: "How Biostatistics Supports Clinical Research"

Tang Xuewen
Co-Founder, Chongqing Yaoda Big Data Co., Ltd.
Presentation Topic: "Insights into China's New Drug Development Competitive Landscape Through Clinical Trial Big Data"
Event Information
Event Time:
September 2, 2022, 13:30–18:30
(Check-in begins at 13:00)
Event Venue:
Hejisheng Conference Room, Floor 1, Building A, Building 1 (Tianhe Incubator Park), No. 1480 North Section of Tianfu Avenue, Chengdu Hi-Tech Zone
Scan the QR Code to Register:

About EClinCloud
EClinCloud provides an integrated, unified cloud platform (including solutions such as CTMS, eTMF, EDC, RTSM, eCOA, and eConsent and consulting services such as scale management, linguistic validation, rater training, study build and configuration, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including oncology, neurology, cardiology, pulmonology, and dermatology). Combining cutting-edge technology with life sciences data, EClinCloud is building a globally leading "patient-centric" SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



